Coeptis Therapeutics, Inc.COEPNASDAQ
LOADING
|||
Operating Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
45.21%
↑ 100% above average
Average (29q)
-18365.23%
Historical baseline
Range
High:100.00%
Low:-543896.88%
Volatility
-2962.1%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 45.21% |
| Q2 2025 | -11.44% |
| Q1 2025 | -87.63% |
| Q4 2024 | -0.95% |
| Q3 2024 | 24.27% |
| Q2 2024 | 3.23% |
| Q1 2024 | 13.18% |
| Q4 2023 | 57.40% |
| Q3 2023 | -114.42% |
| Q2 2023 | 43.65% |
| Q1 2023 | -103.11% |
| Q4 2022 | 41.60% |
| Q3 2022 | 43.46% |
| Q2 2022 | 37.96% |
| Q1 2022 | -5431.69% |
| Q4 2021 | 95.91% |
| Q3 2021 | -164.78% |
| Q2 2021 | -54.35% |
| Q1 2021 | -248.83% |
| Q4 2020 | 0.00% |
| Q3 2020 | 100.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |
| Q4 2005 | -1443.54% |
| Q3 2005 | 95.00% |
| Q2 2005 | -543896.88% |
| Q1 2005 | 0.00% |
| Q4 2004 | 0.00% |
| Q3 2004 | 0.00% |